NDC 73540-003
Yakkongmo treatment
Pyrithione Zinc, Dexpanthenol, Niacinamide, Biotin
Yakkongmo treatment is a Topical Liquid in the Human Otc Drug category. It is labeled and distributed by Bobsnu Co., Ltd.. The primary component is Salicylic Acid; Pyrithione Zinc; Dexpanthenol.
| Product ID | 73540-003_9f273fc5-32f9-a1b9-e053-2995a90aa870 |
| NDC | 73540-003 |
| Product Type | Human Otc Drug |
| Proprietary Name | Yakkongmo treatment |
| Generic Name | Pyrithione Zinc, Dexpanthenol, Niacinamide, Biotin |
| Dosage Form | Liquid |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2020-02-22 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | BOBSNU CO., LTD. |
| Substance Name | SALICYLIC ACID; PYRITHIONE ZINC; DEXPANTHENOL |
| Active Ingredient Strength | 0 g/100mL; g/100mL; g/100mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |